VivoSense Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series B
- Investors
-
5
VivoSense General Information
Description
Developer of real-world digital clinical measures designed to improve patient clinical research and care. The company's platform specializes in wearable sensor physiological monitoring alternatives for the delivery of digital biomarkers from wearable sensor data in regulated clinical trials, enabling researchers to obtain real-world data and analyze it appropriately and accurately in decisions, and evaluate risks associated with various medical treatments.
Contact Information
Website
www.vivosense.comCorporate Office
- 23 Corporate Plaza Drive
- Newport Coast, CA 92660
- United States
Corporate Office
- 23 Corporate Plaza Drive
- Newport Coast, CA 92660
- United States
VivoSense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 18-Oct-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A1) | 04-Mar-2022 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 29-May-2019 | $2M | $4M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Sep-2011 | $2M | $2M | Completed | Startup |
VivoSense Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A | ||||||||
| Seed | 1,306,666 | $0.000100 | $1.53 | $1.53 | 1x | $1.53 | 4.93% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VivoSense Comparisons
Industry
Financing
Details
VivoSense Competitors (1)
One of VivoSense’s competitors is Koneksa, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Koneksa | Venture Capital-Backed | New York, NY |
VivoSense Signals
VivoSense Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| Draper Associates | Venture Capital | Minority | ||
| Perceptive Advisors | Venture Capital | Minority | ||
| Xontogeny | Accelerator/Incubator | Minority | ||
| U.S. Department of Health and Human Services | Government |
VivoSense FAQs
-
When was VivoSense founded?
VivoSense was founded in 2010.
-
Where is VivoSense headquartered?
VivoSense is headquartered in Newport Coast, CA.
-
What is the size of VivoSense?
VivoSense has 35 total employees.
-
What industry is VivoSense in?
VivoSense’s primary industry is Decision/Risk Analysis.
-
Is VivoSense a private or public company?
VivoSense is a Private company.
-
What is VivoSense’s current revenue?
The current revenue for VivoSense is .
-
How much funding has VivoSense raised over time?
VivoSense has raised $29M.
-
Who are VivoSense’s investors?
Debiopharm Innovation Fund, Draper Associates, Perceptive Advisors, Xontogeny, and U.S. Department of Health and Human Services have invested in VivoSense.
-
Who are VivoSense’s competitors?
Koneksa is a competitor of VivoSense.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process